Search

everythinglearnresearchcommunity

for

Search:↓

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

The document concludes that the exact way alcohol causes harm to fetal development is unknown, but it significantly affects nutrient transport to the fetus and a safe level of alcohol during pregnancy is not determined.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

A new mutation in the AGPAT2 gene causes severe fat tissue loss and related health issues by reducing the protein's levels.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Vitamin D is linked to hair health, but more research is needed for its use in treating female hair loss.

ADAM17 could be a potential target for treating PCOS.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

PCOS treatment should be personalized based on its type and the patient's reproductive goals.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

FFA's causes may include environmental triggers and genetic factors.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Keratin is crucial for keeping skin cells healthy and its changes can lead to diseases and affect cell behavior.

Electrospun scaffolds can improve healing in diabetic wounds.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

The CRH/CRH-R1 system might be involved in causing lichen planus.

Future acne treatments should aggressively target inflammation to prevent scarring.